Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Gynecologic 5Breast 2Other 1

Conditions

Endometrial Neoplasms 5Endometrial Hyperplasia 2Breast Neoplasms 2Overweight 1Obesity 1Neoplasms 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Hysteroscopy × Gynecologic × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT05977829 2023-12-26

TamAUB

University of Campania Luigi Vanvitelli

Completed
283 enrolled
Gynecologic

Endometrial Neoplasms

NCT05717634 2023-02-08

Endometrial Changes in Breast Cancer Women.

Regina Elena Cancer Institute

Unknown
829 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Hyperplasia, Endometrial Neoplasms

NCT03898947 2020-03-25

BETA-1

Università degli Studi dell'Insubria

Completed
1,329 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT01961102 2016-08-09

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Krankenhaus Barmherzige Schwestern Linz

Completed
300 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡